AI Money Starts Rotating

The AI trade is not dying; it is moving. Morgan Stanley said in a note dated Monday that the recent weakness in US semiconductor stocks signals a broadening of market gains, with investors likely to rotate out of chipmakers and into AI "hyperscalers" — the tech giants spending billions on data centres — followed by consumer discretionary, transport and biotechnology shares.

What's driving the rotation

Chip stocks have been the runaway winners of the AI buildout. The Philadelphia SE Semiconductor Index climbed 11% in June alone, powered by the massive infrastructure commitments of Alphabet, Amazon, Microsoft and Meta Platforms. But the index has since fallen more than 11% in two weeks, while the Magnificent Seven names, which were heavily sold in June, have recovered ground.

Morgan Stanley's argument is twofold. First, hyperscalers have already endured their period of underperformance, and greater capex discipline in the near term would flip the market narrative in their favour: less spending is a negative for chip suppliers like Nvidia, Advanced Micro Devices, Broadcom and Taiwan Semiconductor, but a margin positive for the companies writing the cheques. Second, macro forces are doing part of the work — markets paring back expectations of Federal Reserve rate hikes and falling crude oil prices are pushing money out of the red-hot chips trade and into rate-sensitive and consumer-facing corners of the market.

The issue hanging over the whole trade is that clear evidence that AI products generate returns justifying the spending has yet to emerge. A rotation toward hyperscalers is, in effect, a bet that they will capture those returns when they arrive.

The immediate beneficiaries: hyperscalers

The direct winners of the rotation Morgan Stanley describes are the data-centre giants themselves — Alphabet (GOOG), Amazon (AMZN), Microsoft (MSFT), Meta Platforms (META) and Oracle (ORCL). Adjacent AI cloud infrastructure plays such as CoreWeave, also sit on the receiving end of hyperscaler demand rather than chip pricing.

The next wave: three sectors to watch

Consumer discretionary. A market pricing in fewer rate hikes and cheaper oil is a market pricing in a stronger consumer. Broad exposure is available through the Consumer Discretionary Select SPDR.

Transport. Falling crude directly cuts fuel costs — the largest variable expense for airlines and freight operators — while a resilient economy lifts volumes. The iShares Transportation Average ETF covers this sector.

Biotechnology. Biotech is among the most rate-sensitive sectors in the market — long-duration cash flows benefit disproportionately when rate-hike expectations fade. The iShares Biotechnology ETF gives broad exposure.

Market Sentiment: 

Sentiment around the chipmakers — Nvidia (NVDA), AMD (AMD), Broadcom (AVGO) and TSMC (TSM) — has turned cautious in the near term, with the SOX's 11% two-week slide suggesting investors are locking in profits after an extended run rather than abandoning the AI thesis outright. For the hyperscalers (GOOGL, AMZN, MSFT, META, ORCL), the note is a clear sentiment positive: the framing that their underperformance is behind them and that capex discipline would reward rather than punish them gives buyers a fresh narrative, and early evidence of the Magnificent Seven recovering lost ground supports it. Sentiment toward consumer discretionary, transport and biotech is turning constructively bullish on the macro tailwinds of softer rate expectations and cheaper oil. However, this leg of the rotation is the most speculative — it depends on the Fed and oil trends holding, and on the broadening actually materialising rather than money simply round-tripping back into chips on the next AI catalyst. The overhang for the entire complex remains unchanged: until AI products demonstrably earn back the capex, every leg of this trade is running on expectation rather than proof.

Disclaimer:
This content has been generated using AI technology and is intended for informational purposes only. While efforts have been made to ensure accuracy and relevance, this text should not be considered professional advice or an official statement. Always verify information from authoritative sources before making any decisions. This is not financial advice.